​

Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?

OverviewForecastRevenueFinancialsChart

Bicycle Therapeutics Ownership Summary

Bicycle Therapeutics is owned by 47.07% institutional investors, 1.40% insiders, and 51.53% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.72% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.56% of its assets in Bicycle Therapeutics shares.

BCYC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicycle Therapeutics47.07%1.40%51.53%
SectorHealthcare Stocks 42.54%10.82%46.64%
IndustryBiotech Stocks 45.21%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp10.89M15.72%$84.25M
Fcpm iii services b.v.3.45M4.99%$26.72M
Armistice capital2.98M4.30%$23.05M
Westfield capital management co lp2.95M4.26%$22.85M
Siren2.01M2.91%$15.58M
Long focus capital management1.42M2.05%$10.98M
Price t rowe associates inc /md/1.38M2.00%$10.72M
Acadian asset management1.31M1.90%$10.15M
Candriam s.c.a.1.17M1.69%$9.07M
Principal financial group1.15M1.66%$8.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.3.45M5.34%$26.72M
Aquilo capital management171.69K2.61%$1.46M
Birchview capital, lp154.00K0.90%$1.19M
Nan fung group68.94K0.90%$533.62K
Rangeley capital130.00K0.87%$1.01M
Siren2.01M0.61%$15.58M
Baker bros. advisors lp10.89M0.61%$84.25M
Monimus capital management, lp85.22K0.41%$659.63K
Long focus capital management1.42M0.36%$10.98M
Armistice capital2.98M0.34%$23.05M

Top Buyers

HolderShares% AssetsChange
Acadian asset management1.31M0.02%616.05K
Principal financial group1.15M0.00%451.13K
Millennium management453.43K0.00%276.67K
Silvercrest asset management group476.98K0.02%211.28K
Renaissance518.70K0.01%200.30K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---3.25M
Point72 asset management430.90K0.01%-1.34M
Deep track capital, lp---1.20M
Ra capital management---1.09M
Bnp paribas asset management---1.04M

New Positions

HolderShares% AssetsChangeValue
Birchview capital, lp154.00K0.90%154.00K$1.19M
State of new jersey common pension fund d20.11K0.00%20.11K$155.61K
Vanguard personalized indexing management12.95K0.00%12.95K$100.26K
Xtx topco11.65K0.00%11.65K$90.16K
Commonwealth of pennsylvania public school empls retrmt sys10.12K0.00%10.12K$78.30K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-4.00
Northwestern mutual wealth management-5.00
Mather group, llc.-5.00
Steward partners investment advisory-10.00
Bell investment advisors-22.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202594-16.07%32,600,347-18.41%471.41%46-26.98%20-4.76%
Jun 30, 202511518.56%41,177,900-1.34%591.63%6653.49%21-30.00%
Mar 31, 20251-99.00%68,943-99.84%-0.00%--100.00%--100.00%
Dec 31, 202499-10.00%41,889,6823.58%601.77%44-16.98%3612.50%
Sep 30, 20241101.85%40,440,4271.84%581.00%55-9.84%3228.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Health Sciences1.08M1.56%-12.15K
Harbor Small Cap Growth Instl970.00K1.40%-30.82K
Westfield Capital Mgt Co Sm-Cap Gr Eq970.00K1.40%-30.82K
Candriam Eqs L Biotech C USD Cap805.24K1.16%-
BNP Paribas Health Cr Innovtr Cl Cap567.98K0.82%-563.00
Principal SmallCap R5538.99K0.78%200.69K
Candriam Global Equities Oncology492.11K0.71%125.18K
BNP Paribas US Small Cap ClassicC476.45K0.69%1.24K
BNP Paribas US Small Cap Classic R468.06K0.68%-9.43K
Belfius Equities Cure C Cap367.15K0.53%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 02, 2025Lee Kevin CHIEF EXECUTIVE OFFICERSell$19.01K
Oct 03, 2025Lee Kevin CHIEF EXECUTIVE OFFICERSell$27.17K
Oct 03, 2025Skynner Michael CHIEF TECHNOLOGY OFFICERSell$8.22K
Oct 02, 2025Skynner Michael CHIEF TECHNOLOGY OFFICERSell$6.92K
Oct 02, 2025Milnes Alistair CHIEF OPERATING OFFICERSell$9.63K

Insider Transactions Trends

DateBuySell
2025 Q3-11
2025 Q2-11
2025 Q1-15
2024 Q41011
2024 Q3-7

BCYC Ownership FAQ

Who Owns Bicycle Therapeutics?

Bicycle Therapeutics shareholders are primarily institutional investors at 47.07%, followed by 1.40% insiders and 51.53% retail investors. The average institutional ownership in Bicycle Therapeutics's industry, Biotech Stocks , is 45.21%, which Bicycle Therapeutics exceeds.

Who owns the most shares of Bicycle Therapeutics?

Bicycle Therapeutics’s largest shareholders are Baker bros. advisors lp (10.89M shares, 15.72%), Fcpm iii services b.v. (3.45M shares, 4.99%), and Armistice capital (2.98M shares, 4.30%). Together, they hold 25.00% of Bicycle Therapeutics’s total shares outstanding.

Does Blackrock own Bicycle Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicycle Therapeutics.

Who is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.34% of its assets in 3.45M Bicycle Therapeutics shares, valued at 26.72M$.

Who is the top mutual fund holder of Bicycle Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Bicycle Therapeutics shares, with 1.56% of its total shares outstanding invested in 1.08M Bicycle Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools